The Chinese company CanSino will also announce the results of its phase 3, which began in October.
Entrepreneur New Years Leader
Get inspiration from the business resources in our guide and help you meet your goals in 2021.
3 min read
This article has been translated from our Spanish edition using AI technologies. Errors can occur due to this process.
This story originally appeared on Alto Nivel
Foreign Minister Marcelo Ebrard announced on his Twitter account that the vaccines CUREVAC (German) and Novavax (USA) in Mexico would start with phase 3 and that the doses required for them would arrive next week.
He added that the Chinese CanSino vaccine, which has 15,000 volunteers in Mexico, will showcase the results of its phase 3, which began in October.
I inform you that the vaccines CUREVAC (Germany) and Novavax (EU) are starting phase 3 in Mexico. The required vaccines will arrive next week. For its part, CanSino (15,000 volunteers in Mexico) will present the results of its Phase 3, which began in October.
– Marcelo Ebrard C. (@m_ebrard) January 22, 2021
In the case of the German company, it will start in Monterrey in cooperation with TecSalud, for which it is looking for between 2,000 and 3,000 Mexican volunteers, the expected start date will be in the last week of January, according to doctor Michelle Martínez, head of the epidemiological surveillance department at TecSalud and head of the Covid-19 program.
Novavax, on the other hand, will be looking for volunteers who are among the population groups most affected by the SARS-CoV-2 virus, as well as older adults or those with comorbidities.
To learn more: Cofepris Approved Phase 3 of Germany's CureVac Vaccine in Mexico
What is known about the CUREVAC vaccine?
The German CUREVAC vaccine consists of two doses and uses the same technology as Pfizer / BioNTech and Moderna, the messenger RNA.
CureVac plans to launch the anti-covid vaccine this year. It can be stored at refrigerator temperature for three months, unlike Pfizer, which requires -70 degrees, and Modern at -20 degrees.
About the Novavax vaccine:
Novavax is an American company that develops vaccines. It is used in two doses 21 days apart. He showed a robust response in phases 1 and 2 that produced strong neutralizing antibodies against the virus.
"Our vaccine technology combines the power and speed of genetic engineering with the immunogenicity-enhancing properties of our Matrix-M adjuvant to efficiently produce highly immunogenic particles that target some of the most pressing viral infectious diseases." according to the information on the Novavax site.
More than 22,000 volunteers have participated in NVX-CoV2373 clinical trials worldwide. Learn about clinical trial registration and advances toward diversity demographics, including PREVENT-19. https://t.co/Nwrpc1hCPC
– Novavax (@Novavax) January 21, 2021
In case you are interested, what are the differences between the three main vaccines against COVID-19?